The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 18, 2022
Filed:
Aug. 24, 2018
Applicant:
Cephalon, Inc., North Wales, PA (US);
Inventors:
Parameswaran Nair, Dundas, CA;
Manali Mukherjee, Hamilton, CA;
Assignee:
Cephalon, Inc., North Wales, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 9/00 (2006.01); A61P 11/06 (2006.01); C07K 16/24 (2006.01); C07K 14/54 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 9/0019 (2013.01); A61P 11/06 (2018.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 14/5409 (2013.01); C07K 16/244 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract
Disclosed herein are methods of treating severe glucocorticoid-dependent eosinophilic asthma in a subject whose asthma has been inadequately controlled with subcutaneously-administered mepolizumab. Also provided are methods of predicting responsiveness to anti-IL-5 antibody treatment in a subject having severe glucocorticoid-dependent eosinophilic asthma.
Nair, Parameswaran. (2022). Treatment strategy for non-responders to 100mg subcutaneous mepolizumab (U.S. Patent No. 11224653). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11224653
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile